Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.

Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, Peacock M.

J Clin Endocrinol Metab. 2009 Aug;94(8):2766-72. doi: 10.1210/jc.2008-2640. Epub 2009 May 26.

PMID:
19470620
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.

Dong BJ.

Clin Ther. 2005 Nov;27(11):1725-51. Review.

PMID:
16368445
[PubMed - indexed for MEDLINE]
3.

Update on the use of cinacalcet in the management of primary hyperparathyroidism.

Marcocci C, Cetani F.

J Endocrinol Invest. 2012 Jan;35(1):90-5. doi: 10.3275/8112. Epub 2011 Nov 21. Review.

PMID:
22104762
[PubMed - indexed for MEDLINE]
4.

Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.

Duntas LH, Stathatos N.

Endocrine. 2011 Jun;39(3):199-204. doi: 10.1007/s12020-011-9452-7. Epub 2011 Mar 26. Review.

PMID:
21442382
[PubMed - indexed for MEDLINE]
5.

Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Khan A, Grey A, Shoback D.

J Clin Endocrinol Metab. 2009 Feb;94(2):373-81. doi: 10.1210/jc.2008-1762. Review.

PMID:
19193912
[PubMed - indexed for MEDLINE]
6.

Cinacalcet for the treatment of primary hyperparathyroidism.

Dillon ML, Frazee LA.

Am J Ther. 2011 Jul;18(4):313-22. doi: 10.1097/MJT.0b013e3181bdc3d0. Review.

PMID:
20228675
[PubMed - indexed for MEDLINE]
7.

Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.

Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF.

PLoS Med. 2013;10(4):e1001436. doi: 10.1371/journal.pmed.1001436. Epub 2013 Apr 30. Review.

PMID:
23637579
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

New strategies for the treatment of hyperparathyroidism incorporating calcimimetics.

de Francisco AL.

Expert Opin Pharmacother. 2008 Apr;9(5):795-811. doi: 10.1517/14656566.9.5.795. Review.

PMID:
18345956
[PubMed - indexed for MEDLINE]
9.

[Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl].

Nakanishi S, Fukagawa M.

Clin Calcium. 2007 Jan;17(1):88-92. Review. Japanese.

PMID:
17211098
[PubMed - indexed for MEDLINE]
10.

Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.

Lewiecki EM.

J Clin Densitom. 2010 Oct-Dec;13(4):324-34. doi: 10.1016/j.jocd.2010.06.004. Review.

PMID:
21029971
[PubMed - indexed for MEDLINE]
11.

The role of calcimimetics in the treatment of hyperparathyroidism.

W├╝thrich RP, Martin D, Bilezikian JP.

Eur J Clin Invest. 2007 Dec;37(12):915-22. Review.

PMID:
18036025
[PubMed - indexed for MEDLINE]
12.

Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.

Torres PU.

J Ren Nutr. 2006 Jul;16(3):253-8. Review.

PMID:
16825031
[PubMed - indexed for MEDLINE]
13.

[Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism].

Vestergaard P, Nielsen LR, Mosekilde L.

Ugeskr Laeger. 2006 Jan 3;168(1):29-32. Review. Danish.

PMID:
16393559
[PubMed - indexed for MEDLINE]
14.

Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis.

Cohen JB, Gordon CE, Balk EM, Francis JM.

Transplantation. 2012 Nov 27;94(10):1041-8. doi: 10.1097/TP.0b013e31826c3968. Review.

PMID:
23069843
[PubMed - indexed for MEDLINE]
15.

Cinacalcet hydrochloride.

Barman Balfour JA, Scott LJ.

Drugs. 2005;65(2):271-81. Review.

PMID:
15631545
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk